Aberdeen Group’s Health Catalyst HCAT Stock Holding History

Aberdeen Group’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,422,201	Closed	-$20.6M	–	938
2022 Q2	$20.6M	Sell	1,422,201 -20,383	-1%	-$348K	0.06%	278
2022 Q1	$37.7M	Buy	1,442,584 +345,137	+31%	+$9.79M	0.1%	219
2021 Q4	$43.5M	Buy	1,097,447 +100,829	+10%	+$4.6M	0.1%	213
2021 Q3	$49.8M	Buy	996,618 +992,372	+23,372%	+$54.1M	0.11%	190
2021 Q2	$236K	Buy	+4,246	New	+$226K	﹤0.01%	992
2020 Q2	–	Sell	-23,060	Closed	-$603K	–	933
2020 Q1	$603K	Buy	+23,060	New	+$705K	﹤0.01%	818

Other funds holding HCAT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Aberdeen Group's HCAT Position: Q3 2022 in Review

Aberdeen Group sold out of Health Catalyst (HCAT) in Q3 2022, closing a stake of 1,422,201 shares — an estimated $20.6M sold.

Aberdeen Group first reported a position in HCAT in Q1 2020 and held it in 6 quarters. The position peaked at $49.8M in Q3 2021. 171 funds tracked by Wall St. Rank hold HCAT as of Q3 2022.

Aberdeen Group reported no remaining Health Catalyst position as of Q3 2022 after selling out during the quarter.
Aberdeen Group sold 1,422,201 Health Catalyst shares in Q3 2022, an estimated $20.6M.
Aberdeen Group first reported a position in Health Catalyst in Q1 2020 and held it in 6 quarters.
Aberdeen Group's Health Catalyst position peaked at $49.8M in Q3 2021.
171 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2022.

Based on Aberdeen Group's 13F filing for Q3 2022, filed 10 Nov 2022.